Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells

The aim of this study was to evaluate the prognostic impact of the F-fluorodeoxyglucose positron emission tomography response at 1 month (M1) and 3 months (M3) after anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in a multicenter cohort of 160 patients with relapsed/refractory large B-cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Galtier, Jean, Vercellino, Laetitia, Chartier, Loic, Olivier, Pierre, Tabouret-Viaud, Claire, Mesguich, Charles, Di Blasi, Roberta, Durand, Amandine, Raffy, Léo, Gros, François-Xavier, Madelaine, Isabelle, Meignin, Veronique, Mebarki, Miryam, Rubio, Marie-Thérèse, Feugier, Pierre, Casasnovas, Olivier, Meignan, Michel, Thieblemont, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Non-Hodgkin Lymphoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827160/
https://www.ncbi.nlm.nih.gov/pubmed/35678029
http://dx.doi.org/10.3324/haematol.2021.280550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827160/
https://www.ncbi.nlm.nih.gov/pubmed/35678029
http://dx.doi.org/10.3324/haematol.2021.280550

Ejemplares similares